title: Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosages.
authors.affiliation: a Research Laboratories , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Prerna K
authors.initials: PK
authors.lastname: Chawla
authors.affiliation: b Department of Lab Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Rohan V
authors.initials: RV
authors.lastname: Lokhande
authors.affiliation: b Department of Lab Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Prasad R
authors.initials: PR
authors.lastname: Naik
authors.affiliation: a Research Laboratories , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.|b Department of Lab Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Alpa J
authors.initials: AJ
authors.lastname: Dherai
authors.affiliation: c Department of Respiratory Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Rohit A
authors.initials: RA
authors.lastname: Amale
authors.affiliation: c Department of Respiratory Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Zarir F
authors.initials: ZF
authors.lastname: Udwadia
authors.affiliation: c Department of Respiratory Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Ashok A
authors.initials: AA
authors.lastname: Mahashur
authors.affiliation: d Department of Internal Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Rajeev
authors.initials: R
authors.lastname: Soman
authors.affiliation: a Research Laboratories , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.|b Department of Lab Medicine , P.D. Hinduja Hospital & MRC , Mahim, Mumbai , India.
authors.forename: Tester F
authors.initials: TF
authors.lastname: Ashavaid
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin